Investors
Care between visits, measured
Desha.ai is the health platform for the days between visits. It measures the health that happens outside the clinic: a daily AI voice check-in in 21 languages that asks how you are, the family kept in the loop, wearables and a recovery plan agreed with your doctor. All of it becomes one Health Responsibility Score, 100 to 1000, that patients, families and clinicians can act on.
Pre-seed · SEIS and EIS advance assurance approved · London and Hyderabad

Sample data. The morning briefing is the design of record, in build.

What is live
- Sample data

MedNote
Daily check-in, family circle, prescription scan and recovery plan, on iOS and Android.
- Sample data

DocNote
A web workspace for clinicians: flags, pre-consult briefs and messages.
- Sample data

HeartBeat
The voice and agent engine behind both: daily AI check-ins in 21 languages.
- Sample data

Health Responsibility Score
The score both products share, from 100 to 1000. Not a medical test.
AI voice calls are live in the UK and EU. India is on regulatory hold; WhatsApp and app reminders reach India. Sample data.
From our first pilot
Pilot of 50 patients, self-reported, not a clinical study
50
patients in the pilot
80%
40/50
answered the AI voice call
64%
32/50
added a family member
20%
10/50
chose a paid plan
70–80%
30-day retention
Adherence lift 70% (self-reported).
Market
- Total market
- $285B global digital health (to ~$946B by 2030, 22% CAGR — Grand View 2025)
- Serviceable market
- ~$66B between-visit chronic care (UK ~$42B + India/GCC ~$24B by 2030)
Stage
Raising a pre-seed round. SEIS and EIS advance assurance is approved, and we are filling the SEIS and EIS allocations now. Founded 2025, offices in London and Hyderabad.
Why now
- Voice AI is finally natural enough for someone in their eighties.
- Between-visit care is now reimbursable in the US.
- Chronic disease keeps rising.
Want the deck, or 30 minutes with the team?
Pre-seed · SEIS and EIS advance assurance approved · London and Hyderabad
Pilot figures are not a clinical study, and adherence is self-reported. Screens show sample data.